首页> 美国卫生研究院文献>Neuro-Oncology >BM-20EVALUATION OF RISK FACTORS FOR DEATH WITHIN THREE MONTHS AFTER STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES
【2h】

BM-20EVALUATION OF RISK FACTORS FOR DEATH WITHIN THREE MONTHS AFTER STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES

机译:BM-20对脑转移瘤进行立体定向放射手术后三个月内死亡危险因素的评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: Stereotactic radiosurgery (SRS) is used commonly for patients with brain metastases (BM) to improve intracranial disease control. However, survival of these patients is most often dictated by the course of their systemic disease, and use of SRS for all patients with BMs is not an appropriate use of limited medical resources. We evaluated prognostic factors which may predict early death (within 90 days) after SRS. METHODS: 1427 patients with BM were treated with SRS at our institution (2000-2012) and their data are maintained in an IRB approved database. 1395 cases were included in this study. The primary end point of the study was mortality within 90 days after first SRS. Multivariate analysis was performed and a predictive model was developed to determine a prognostic index for 90-day mortality. RESULTS: Overall, 53% of patients were female, median age at diagnosis of the primary cancer was 58 years. Multiple BM was observed in 773 patients (55%), 108 patients (8%) had KPS 60 or lower at time of SRS and 1069 patients (77%) had other extra-cranial metastases. 263 patients (19%) died within 90 days after SRS. Multivariate analysis showed that KPS (p < 0.0001), extracranial metastases at SRS (p < 0.0001), number and size of BM (p = 0.003), and prior surgery (p = 0.001) were independent prognostic factors for 90-day mortality. We developed a prognostic model by assigning a weighted score to each significant factor from the multivariate analysis that is proportional to its hazard ratio. The total score for each patient was determined by summation, and four independent prognostic groups could be determined from the total scores. We found that the lowest scoring group had a 44% chance of early mortality versus 4% in highest scoring group (P < 0.0001). CONCLUSIONS: Prospective validation of this 90-day mortality risk prognostic model may provide a valuable tool for appropriate clinical resource utilization.
机译:背景:立体定向放射外科(SRS)通常用于脑转移(BM)患者,以改善颅内疾病的控制。但是,这些患者的生存通常取决于其全身疾病的病程,并且对所有患有BMs的患者使用SRS并不是有限医疗资源的适当使用。我们评估了预后因素,这些因素可以预测SRS后的早期死亡(90天内)。方法:2000-2012年,我们机构对1427例BM患者进行了SRS治疗,其数据保存在IRB批准的数据库中。本研究包括1395例病例。该研究的主要终点是首次SRS后90天内的死亡率。进行多变量分析并建立预测模型,以确定90天死亡率的预后指标。结果:总体上,有53%的患者为女性,诊断为原发癌的中位年龄为58岁。在SRS时,有773例患者(55%),108例患者(8%)的KPS≤60和1069例患者(77%)的其他颅外转移患者出现了多发性BM。 263名患者(19%)在SRS后90天内死亡。多因素分析显示,KPS(p <0.0001),SRS颅外转移(p <0.0001),BM的数量和大小(p = 0.003)和先前的手术(p = 0.001)是90天死亡率的独立预后因素。我们通过对与风险比成正比的多元分析中的每个重要因素分配加权得分,从而开发了一种预测模型。通过求和确定每个患者的总得分,并可以从总得分中确定四个独立的预后组。我们发现得分最低的组发生早期死亡的几率为44%,而得分最高的组为4%(P <0.0001)。结论:90天死亡风险预后模型的前瞻性验证可能为适当利用临床资源提供有价值的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号